Rockwell Medical (RMTI) Tops Q1 EPS by 3c, provides guidance

Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.01), $0.03 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $18.9 million versus the consensus estimate of $19.14 million.

GUIDANCE:

Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $67.424 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• DA Davidson Reiterates Neutral Rating on Brunswick Corp (BC)
• RCM Technologies (RCMT) PT Raised to $45 at Benchmark on Q2 Beat